Arrowhead Pharmaceuticals, Inc. ARWR
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| William Pickering | Bernstein | 25.8114 $ | 24 $ | -1.81 % | 29/11/2024 |
| Keay Nakae | Loop Capital Markets | 12.9 $ | 60 $ | 47.10 % | 27/11/2024 |
| David Lebowitz | Citigroup | 22.91 $ | 27 $ | 4.09 % | 03/09/2024 |
| Patrick Trucchio | H.C. Wainwright | 12.77 $ | 60 $ | 47.23 % | 05/07/2024 |
| Andrea Tan | Goldman Sachs | 25.29 $ | 31 $ | 5.71 % | 05/06/2024 |
| Luca Issi | RBC Capital | 11.43 $ | 50 $ | 38.57 % | 30/05/2024 |
| Madhu Kumar | Goldman Sachs | 53.790001 $ | 85 $ | 31.21 % | 19/01/2022 |